ALX Oncology Holdings Inc.
ALXO • NASDAQ
ALX Oncology Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason W. Lettmann, with a market cap of $223.7M.
Market Cap$223.7M
Employees74.0
CEOJason W. Lettmann
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
ALX Oncology Holdings Inc. FAQ
Common questions about ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
ALX Oncology Holdings Inc. has approximately 74 employees.